Publications

Title

Author

Year

Age- and Sex-Specific Social Contact Patterns and Incidence of Mycobacterium tuberculosis Infection.

Dodd, PJ; Looker, C; Plumb, ID; BOND, V; SCHAAP, A; Shanaube, K; Muyoyeta, M; VYNNYCKY, E; GODFREY-FAUSSETT, P; CORBETT, EL; Beyers, N; AYLES, H; WHITE, RG;

2015

American journal of epidemiology, (2015).183 2 10.1093/aje/kwv160.

Rapid diagnosis of TB in HIV-positive in-patients with M. tuberculosis bacteraemia in sub-Saharan Africa.

LAWN, SD; Kerkhoff, AD;

2015

The international journal of tuberculosis and lung disease, (2015).19 12 10.5588/ijtld.15.0837.

Patients' costs associated with seeking and accessing treatment for drug-resistant tuberculosis in South Africa.

Ramma, L; Cox, H; Wilkinson, L; FOSTER, N; Cunnama, L; VASSALL, A; Sinanovic, E;

2015

The international journal of tuberculosis and lung disease, (2015).19 12 10.5588/ijtld.15.0341.

Implementation and Operational Research: What Happens After a Negative Test for Tuberculosis? Evaluating Adherence to TB Diagnostic Algorithms in South African Primary Health Clinics.

McCarthy, KM; GRANT, AD; Chihota, V; Ginindza, S; Mvusi, L; CHURCHYARD, GJ; FIELDING, KL;

2015

Journal of acquired immune deficiency syndromes (1999), (2015).71 5 10.1097/QAI.0000000000000907.

Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study.

NGUIPDOP-DJOMO, P; Heldal, E; RODRIGUES, LC; Abubakar, I; MANGTANI, P;

2015

The Lancet infectious diseases, (2015).16 2 10.1016/S1473-3099(15)00400-4.

Considering the design effect for the stepped wedge trial: what can it tell us?.

THOMPSON, J; FIELDING, K; HARGREAVES, J; Copas, A;

2015

Trials, (2015).16 S2 10.1186/1745-6215-16-s2-o45.

Isolation and Potential for Transmission of Mycobacterium bovis at Human-livestock-wildlife Interface of the Serengeti Ecosystem, Northern Tanzania.

Katale, BZ; Mbugi, EV; Siame, KK; Keyyu, JD; Kendall, S; Kazwala, RR; DOCKRELL, HM; Fyumagwa, RD; Michel, AL; Rweyemamu, M; Streicher, EM; Warren, RM; Van Helden, P; Matee, MI;

2015

Transboundary and emerging diseases, (2015).64 3 10.1111/tbed.12445.

Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status.

RHODES, SJ; KNIGHT, GM; FIELDING, K; Scriba, TJ; Pathan, AA; McShane, H; FLETCHER, H; WHITE, RG;

2015

Tuberculosis (Edinburgh, Scotland), (2015).96, 10.1016/j.tube.2015.10.002.

Microscopic Observation Drug Susceptibility Assay for Rapid Diagnosis of Lymph Node Tuberculosis and Detection of Drug Resistance.

Kirwan, DE; Ugarte-Gil, C; Gilman, RH; Caviedes, L; Rizvi, H; Ticona, E; Chavez, G; Cabrera, JL; Matos, ED; Evans, CA; MOORE, DA J; Friedland, JS; Lymph Node TB Working Group, Peru,;

2015

Journal of clinical microbiology, (2015).54 1 10.1128/JCM.02227-15.

Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study.

Biraro, IA; EGESA, M; Kimuda, S; SMITH, SG; TOULZA, F; Levin, J; Joloba, M; Katamba, A; COSE, S; DOCKRELL, HM; ELLIOTT, AM;

2015

BMC infectious diseases, (2015).15 1 10.1186/s12879-015-1201-8.